Ulcerative Colitis Update

Content Type: presentation

Presenter: David T. Rubin, MD, FACG

Presenter Disclosure: Advisory Committee/Board Member: Janssen Consultant: AbbVie, Abgenomics, Allergan, Arena Pharmaceuticals, Biomica, Bristol-Myers Squibb, Ferring Pharmaceuticals, Genentech, Janssen, Lilly, Medtronic, Merck, Napo Pharmaceuticals, Pfizer, Shire, Takeda, Target PharmaSolutions, Inc. Grant/Research Support: AbbVie, Genentech, Prometheus Laboratories, Shire, Takeda

Event: 2019 ACG Annual Postgraduate Course

Release Date: 3/10/2020

Expiration Date: 3/10/2023

Objective: Describe the important adverse events that can occur with the use of biologic therapy.